chartexchange

Nuvation Bio to Present at the Jefferies Global Healthcare Conference in London

PR Newswire | Nov 10, 2026 4:05 PM EST

NEW YORK, Nov. 10, 2026 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio, and Philippe...

Read original article